Author:
Zhao Chengcheng,Deng Yuefei,He Yi,Huang Xianjian,Wang Chuanfang,Li Weiping
Funder
National Natural Science Foundation of China
Natural Science Foundation of Guangdong Province
Guangdong Basic and Applied Basic Research Foundation
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Neurology (clinical),Pharmacology
Reference66 articles.
1. Popescu C, Anghelescu A, Daia C, Onose G. Actual data on epidemiological evolution and prevention endeavours regarding traumatic brain injury. Journal of medicine and life. 2015;8(3):272-277.
2. Jiang JY, Gao GY, Feng JF, et al. Traumatic brain injury in China. The Lancet Neurology. 2019;18(3):286-295.
3. Rosenfeld JV, Maas AI, Bragge P, Morganti-Kossmann MC, Manley GT, Gruen RL. Early management of severe traumatic brain injury. Lancet. 2012;380(9847):1088-1098.
4. Gruenbaum SE, Zlotnik A, Gruenbaum BF, Hersey D, Bilotta F. Pharmacologic Neuroprotection for Functional Outcomes After Traumatic Brain Injury: A Systematic Review of the Clinical Literature. CNS drugs. 2016;30(9):791-806.
5. Tsitsopoulos PP, Abu Hamdeh S, Marklund N. Current Opportunities for Clinical Monitoring of Axonal Pathology in Traumatic Brain Injury. Frontiers in neurology. 2017;8:599.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献